Exchange: OTC·Updated 09:53 AM EDT

MBCOF Marvel Biosciences Corp

$0.1106
$0.0071
(6.86%)
Today
Mkt Cap$6.97M
Vol159.00

About MBCOF

Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. It develops several patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases, and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The company was founded on August 1, 2018 and is headquartered in Calgary, Canada.
50

Neutral Sentiment

How do you feel about MBCOF?

Advertisement|Remove ads.